ArticleJAMA network open2021
The Combined Effect of Vaccination and Nonpharmaceutical Public Health Interventions-Ending the COVID-19 Pandemic.
Article in JAMA network open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Non-pharmaceutical interventions in containing COVID-19 pandemic after the roll-out of coronavirus vaccines: a systematic review.BMC public health · 2024Pooled it
- Mask Usage in Healthcare Settings: Is It the Right Time for Easing Restrictions? A Narrative Review.Iranian journal of public health · 2025Review
- Quantitative Synthesis of Factors Associated with COVID-19 Vaccine Acceptance and Vaccine Hesitancy in 185 Countries.Vaccines · 2023Article
- Role of booster vaccines and hybrid immunity against severe COVID-19 outcomes during BA.5 omicron predominance in Thailand.Human vaccines & immunotherapeutics · 2023Article
- Article
- The Role of Vaccination and Face Mask Wearing on COVID-19 Infection and Hospitalization: A Cross-Sectional Study of the MENA Region.Healthcare (Basel, Switzerland) · 2023Article
- Effectiveness of heterologous third and fourth dose COVID-19 vaccine schedules for SARS-CoV-2 infection during delta and omicron predominance in Thailand: a test-negative, case-control study.The Lancet regional health. Southeast Asia · 2023Article
- Hand Hygiene, Face Mask Use, and Associated Factors during the COVID-19 Pandemic among the Students of Mongar Higher Secondary School, Bhutan: A Cross-Sectional Study.International journal of environmental research and public health · 2023Article
- Reduction in severity and mortality in COVID-19 patients owing to heterologous third and fourth-dose vaccines during the periods of delta and omicron predominance in Thailand.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023Article
- Coinfections with SARS-CoV-2 variants and influenza virus during the 2019 Coronavirus disease pandemic in Burkina Faso: A surveillance study.Health science reports · 2023Article
- Effects of the vaccination against SARS-CoV-2 on infections and on hospitalizations in European countries.SN business & economics · 2023Article
- Waning vaccine response to severe COVID-19 outcomes during omicron predominance in Thailand.PloS one · 2023Article
- Article
- Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review.BMJ evidence-based medicine · 2022Article
- Factors associated with COVID-19 masking behavior: an application of the Health Belief Model.Health education research · 2022Article
- Preventive Behaviors and Information Sources during COVID-19 Pandemic: A Cross-Sectional Study in Japan.International journal of environmental research and public health · 2022Article
- Vaccine hesitancy and health care providers: Using the preferred cognitive styles and decision- making model and empathy tool to make progress.Vaccine: X · 2022Article
- The impact of non-pharmaceutical interventions on COVID-19 cases in South Australia and Victoria.Australian and New Zealand journal of public health · 2022Article
- Article
- SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents.Cell reports. Medicine · 2022Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
34061205What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.